Check-Cap Ltd. (CHEK)
Check-Cap Ltd. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Isfiya, IL. The stock last traded at $1.86, up 1.64% on the session, giving a market capitalisation of $10.9M. On trailing twelve-month figures it carries a trailing P/E of -0.43, a net margin of 0.0%. Its beta of 0.46 implies it has historically moved less than the broad market.
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.
Check-Cap Ltd. is most often compared with the following Healthcare names: